Document and Entity Information
Document and Entity Information | Sep. 25, 2020 |
Cover [Abstract] | |
Amendment Flag | true |
Entity Central Index Key | 0001720580 |
Document Type | 8-K/A |
Document Period End Date | Sep. 25, 2020 |
Entity Registrant Name | Adicet Bio, Inc. |
Entity Incorporation State Country Code | DE |
Entity File Number | 001-38359 |
Entity Tax Identification Number | 81-3305277 |
Entity Address, Address Line One | 500 Boylston Street |
Entity Address, Address Line Two | 13th Floor |
Entity Address, City or Town | Boston |
Entity Address, State or Province | MA |
Entity Address, Postal Zip Code | 02116 |
City Area Code | (857) |
Local Phone Number | 315-5528 |
Written Communications | false |
Soliciting Material | false |
Pre Commencement Tender Offer | false |
Pre Commencement Issuer Tender Offer | false |
Security 12b Title | Common Stock, par value $0.0001 per share |
Trading Symbol | ACET |
Security Exchange Name | NASDAQ |
Entity Emerging Growth Company | true |
Entity Ex Transition Period | false |
Amendment Description | This Amendment No. 1 to the Current Report on Form 8-K of Adicet Bio, Inc. (the “Company”) is being filed solely to provide the Exhibit 16.1 letter from the Company’s former auditor, PricewaterhouseCoopers LLP. No changes have been made to the information presented below in item 4.01. |